Olympus EBITDA per Share
The EBITDA per Share of Olympus (7733.T) as of Aug 10, 2026 is 194.29 JPY. In the previous year, EBITDA per Share was 125.74 JPY — a change of 54.51% (higher).
Get this data via API
Financial Data API
EBITDA per Share
194.29JPY
YoY
54.51%
Last updated:
EBITDA per Share of Olympus is 2026 194.29 JPY. EBITDA per Share of Olympus was 2025 125.74 JPY. It decreases by 54.51% higher compared to the previous year.
Access this data via the Eulerpool API
Olympus Stock analysis
What does Olympus do? Olympus Corp is a Japanese company based in Tokyo that specializes in the manufacturing and distribution of optical and medical devices. The company was founded in 1919 and has since become a global company with a wide range of products.
Answer: Olympus Corp is a Japanese company that specializes in the manufacturing and distribution of optical and medical devices. Olympus is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Olympus stock
EBITDA per Share of Olympus is 194.29 JPY in 2026.
EBITDA per Share of Olympus changed from 125.74 JPY to 194.29 JPY, representing a 54.51% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBITDA per Share Olympus since 2006 – with annual values, charts, and detailed analysis.
EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.
Access this data via the Eulerpool API
Income Statement — Olympus
All Key Metrics — Olympus
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth